WolterkMedtronic (NYSE:MDT) has faced several challenges in the past decade. Some were probably because of poor focus and lack of innovation, while others, like COVID-19, were out of their control. Consequently, the share price has languished after peaking in mid-2021. It currently trades at levels in 2018. However, Medtronic is a market leader with solid competitive advantages. Also, performance has recently improved. The stock is undervalued and possesses a nice yield. I expect the dividend streak to ...

PITTSBURGH, Aug. 23, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing, today announced that the Federated Hermes ETF Trust, on behalf of its portfolio, Federated Hermes MDT Large Cap Growth ETF (NYSE: FLCG), which seeks long-term capital appreciation by investing primarily in common stocks of large capitalization (large-cap) U.S. companies with higher forecasted growth values relative to the market, has obtained approval by majority shareholder consent action to c ...

Medtronic TodayMDTMedtronic$87.86 +0.32 (+0.37%) 52-Week Range$68.84▼$89.24Dividend Yield3.19%P/E Ratio31.95Price Target$91.50Add to WatchlistShares of medical device manufacturer Medtronic PLC NYSE: MDT are down about 35% from their highs of roughly three years ago, but promising results from the company's first quarter of fiscal 2025, which ended July 26, could help to drive renewed upward momentum. Specifically, Medtronic's diabetes and neuromodulation products may be poised for breakout growth, and the ...

This photo taken on Nov. 8, 2023 shows a booth of Medtronic at the 6th China International Import ... [+] Expo CIIE in east China's Shanghai. (Photo by Wang Xiang/Xinhua via Getty Images)Xinhua News Agency via Getty ImagesMedtronic (NYSE: MDT) recently reported its Q1 fiscal 2025 results (fiscal ends in April), with revenues and earnings exceeding our estimates. The company reported revenue of $7.9 billion and adjusted earnings of $1.23 per share, compared to our estimates of $7.9 billion and $1.21, respect ...

Medtronic (MDT) reported $7.92 billion in revenue for the quarter ended July 2024, representing a year-over-year increase of 2.8%. EPS of $1.23 for the same period compares to $1.20 a year ago.The reported revenue represents a surprise of +0.22% over the Zacks Consensus Estimate of $7.9 billion. With the consensus EPS estimate being $1.20, the EPS surprise was +2.50%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their n ...

Medtronic plc (MDT) reported adjusted earnings per share (EPS) of $1.23 for first-quarter fiscal 2025, up 2.5% from the year-ago quarter’s figure. The figure also beat the Zacks Consensus Estimate by the same magnitude. Currency-adjusted EPS for the reported quarter was $1.29.Without certain one-time adjustments — including amortization, restructuring and associated costs, certain litigation charges and acquisition-related costs, among others — GAAP EPS was 80 cents, a 35.6% improvement from the year-ago qu ...

Key TakeawaysMedtronic beat first-quarter earnings and revenue estimates on strong sales of its medical devices.Sales were higher at the company's cardiovascular, neuroscience, and diabetes divisions.Medtronic raised the low end of its full-year outlook for its organic revenue growth and adjusted EPS. Medtronic (MDT) shares advanced in intraday trading Tuesday as the medical technology firm posted better-than-expected results and raised its guidance on strong demand for its medical devices. The Ireland-base ...

Medtronic plc (NYSE:MDT) Q1 2025 Earnings Conference Call August 20, 2024 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head, IR Geoff Martha - Chairman and CEO Gary Corona - Interim Chief Financial Officer Brad Welnick - VP, IR Que Dallara - EVP and President, Diabetes Operating Unit Sean Salmon - EVP and President, Cardiovascular Portfolio Mike Marinaro - EVP and President, Medical Surgical Portfolio and Surgical Operating Unit Conference Call Participants Vijay Kumar - Evercore ISI Robert Ma ...

Medtronic (MDT) reported $7.92 billion in revenue for the quarter ended July 2024, representing a year-over-year increase of 2.8%. EPS of $1.23 for the same period compares to $1.20 a year ago.The reported revenue represents a surprise of +0.22% over the Zacks Consensus Estimate of $7.9 billion. With the consensus EPS estimate being $1.20, the EPS surprise was +2.50%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their n ...

Medtronic (MDT) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.50%. A quarter ago, it was expected that this medical device company would post earnings of $1.45 per share when it actually produced earnings of $1.46, delivering a surprise of 0.69%.Over the last four quarters, the co ...